Homozygous deletion of MKK4 in ovarian serous carcinoma

Analysis of deleted chromosomal regions in tumors has historically led to the identification of tumor suppressor genes. In this study, we used digital karyotyping, a genome-wide, high-resolution technology, to search for chromosomal deletions in ovarian serous carcinoma, the most lethal gynecological malignancy in women. Five purified ovarian serous carcinomas were analyzed by digital karyotyping and small interstitial deletions at chromosome 17p were identified in two tumor samples. Aligning these two deletions identified an overlapping region that spanned 2.4 Mb which harbored a candidate tumor suppressor gene, mitogen-activated protein kinase kinase-4 (MKK4). Dual-color FISH analysis confirmed homozygous deletion of the MKK4 locus in both samples and RT-PCR demonstrated that both carcinomas lacked MKK4 transcript expression. Loss of heterozygosity of 17p occurred in 24 (86%) of 28 high-grade serous carcinomas including both cases with homozygous MKK4 deletion. Additionally, downregulation of MKK4 expression was found in 96 (75%) of 128 ovarian serous carcinomas as compared to benign ovarian tissues. These findings suggest that homozygous deletion or reduced expression of MKK4 may contribute to the development of ovarian serous carcinoma.

[1]  Giovanni Parmigiani,et al.  Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[2]  G. Riggins,et al.  Genomic amplification of orthodenticle homologue 2 in medulloblastomas. , 2005, Cancer research.

[3]  R. McLendon,et al.  Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid. , 2005, Cancer research.

[4]  Tian-Li Wang,et al.  Apply innovative technologies to explore cancer genome , 2005, Current opinion in oncology.

[5]  Toshiaki Katada,et al.  Physiological roles of SAPK/JNK signaling pathway. , 2004, Journal of biochemistry.

[6]  A. Groyer,et al.  Disruption of MKK4 signaling reveals its tumor-suppressor role in embryonic stem cells , 2004, Oncogene.

[7]  G. Parmigiani,et al.  Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Tian-Li Wang,et al.  Identifying tumor origin using a gene expression-based classification map. , 2003, Cancer research.

[9]  A. Montag,et al.  Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma. , 2002, Cancer research.

[10]  S. Chi,et al.  Expression and mutation analyses of MKK4, a candidate tumour suppressor gene encoded by chromosome 17p, in human gastric adenocarcinoma. , 2002, European journal of cancer.

[11]  T. Sasaki,et al.  Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1/MKK4. , 1999, Development.

[12]  C. Rubin,et al.  Systematic Reviews: Synthesis of Best Evidence for Health Care Decisions , 1998, Annals of Internal Medicine.

[13]  L. Zon,et al.  SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Hruban,et al.  Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene. , 1998, Cancer research.

[15]  A. Roulston,et al.  Early Activation of c-Jun N-terminal Kinase and p38 Kinase Regulate Cell Survival in Response to Tumor Necrosis Factor α* , 1998, The Journal of Biological Chemistry.

[16]  L. Maffei,et al.  A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias. , 1998, American journal of clinical pathology.

[17]  M. Skolnick,et al.  Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. , 1997, Cancer research.

[18]  R. Flavell,et al.  Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Mak,et al.  Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3 , 1997, Nature.

[20]  R. Davis,et al.  Evidence for a Role of Rho-like GTPases and Stress-activated Protein Kinase/c-Jun N-terminal Kinase (SAPK/JNK) in Transforming Growth Factor β-mediated Signaling* , 1997, The Journal of Biological Chemistry.

[21]  D. Slamon,et al.  Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. , 1996, Oncogene.

[22]  C. Moskaluk,et al.  Homozygous deletion map at 18q21.1 in pancreatic cancer. , 1996, Cancer research.

[23]  J. Tucker,et al.  Fluorescence in situ hybridization: A brief review , 1996, Environmental and molecular mutagenesis.

[24]  M. Bittner,et al.  Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Skolnick,et al.  A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.